Adicet Bio, Inc. (ACET) Insider Trading -- Recent Executive & Director Transactions

21 insiders reported 73 Form 4 transactions for Adicet Bio, Inc. (ACET) over the past 18 months (most recent 2026-04-29). Recent activity: Kolchinsky Peter (10% Owner) Sell 250,000 shares, Shah Rajeev M. (10% Owner) Sell 250,000 shares, RA CAPITAL MANAGEMENT, L.P. (10% Owner) Sell 250,000 shares, RA Capital Healthcare Fund LP (10% Owner) Sell 250,000 shares, Shah Rajeev M. (10% Owner) Buy 74,751 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-04-29Kolchinsky Peter10% OwnerSell250,000$0
2026-04-29Shah Rajeev M.10% OwnerSell250,000$0
2026-04-29RA CAPITAL MANAGEMENT, L.P.10% OwnerSell250,000$0
2026-04-29RA Capital Healthcare Fund LP10% OwnerSell250,000$0
2026-04-13Shah Rajeev M.10% OwnerBuy74,751$543,440
2026-04-13Kolchinsky Peter10% OwnerBuy74,577$525,022
2026-04-13RA CAPITAL MANAGEMENT, L.P.10% OwnerBuy74,577$525,022
2026-04-13RA Capital Healthcare Fund LP10% OwnerBuy74,577$525,022
2026-04-13Shah Rajeev M.10% OwnerBuy74,268$535,472
2026-04-13Kolchinsky Peter10% OwnerBuy74,268$535,472
2026-04-13RA CAPITAL MANAGEMENT, L.P.10% OwnerBuy74,268$535,472
2026-04-13RA Capital Healthcare Fund LP10% OwnerBuy74,268$535,472
2026-04-13Shah Rajeev M.10% OwnerBuy74,577$525,022
2026-04-13Kolchinsky Peter10% OwnerBuy74,751$543,440
2026-04-13RA Capital Healthcare Fund LP10% OwnerBuy74,751$543,440
2026-04-13RA CAPITAL MANAGEMENT, L.P.10% OwnerBuy74,751$543,440
2026-04-09OrbiMed Israel GP II, L.P.10% OwnerSell2,400$15,312
2026-04-09OrbiMed Israel GP II, L.P.10% OwnerSell29,319$191,453
2026-04-09OrbiMed Israel GP Ltd.10% OwnerSell29,319$191,453
2026-04-09OrbiMed Israel BioFund GP Limited Partnership10% OwnerSell29,319$191,453
2026-04-09OrbiMed Capital GP V LLC10% OwnerSell29,319$191,453
2026-04-09OrbiMed Advisors Israel II Ltd10% OwnerSell29,319$191,453
2026-04-09OrbiMed Capital GP VI LLC10% OwnerSell29,319$191,453
2026-04-09ORBIMED ADVISORS LLC10% OwnerSell29,319$191,453
2026-04-09OrbiMed Genesis GP LLC10% OwnerSell29,319$191,453

Source: SEC Form 4 filings · as of 2026-04-29